Dr. Eric Zhao is a scientist in the Research and Development department at GENEWIZ. He leads projects that include development and implementation of high-quality plasmid DNA preparation, viral vector manufacturing, and gene synthesis. He understands the importance and challenges of obtaining high-quality starting materials for gene and cell therapies using viral vectors, such as AAV. His interest in treating diseases using viral vectors began during his postdoc at Columbia University, where he used viral vectors and mouse models to study a neurodegenerative disease named CMT. He gained his Ph.D. in Biological Sciences from Fordham University, where he studied the molecular and physiological mechanisms of Kv mutations found in SCA diseases.